News

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...
The administration in May canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans. When asked about the uncertain regulatory environment in the U.S., ...
Warren and Duckworth demanded Kennedy make the review public, alongside a similar review the department cited when it cut ...
The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.
The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...
Amidst an ongoing outbreak of a deadly bird flu virus in livestock, the US Department of Agriculture is doing more to prevent ...
Earlier this month, Moderna said it no longer expects to get approval for a combined COVID-19 and flu shot this year. The company said it may continue developing the bird flu vaccine on its own.